Sodium oligo-mannurarate 600mg for cognitive dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Oct 2011: Trial registered, NCT01453569

The trials

NCT01453569: Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

State
Completed
Phase
Phase 2
People
255 taking part
Started
Oct 2011
Primary completion
Aug 2013
Arms
sodium oligo-mannurarate 600mg
Results
Posted on the registry
  1. 18 Oct 2011: Trial registered
  2. 27 Jan 2015: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.